Sharklet Technologies, Inc.
1 like902 views
ClearSightTM is an intraocular lens (IOL) platform designed to eliminate posterior capsule opacification (PCO) using SharkletTM technology. It has multiple issued patents and shown strong results in vivo, reducing cell migration by 80% and treatable PCO by 100% in studies. The ClearSightTM IOL addresses a significant problem in a large market by being the first IOL designed to eliminate PCO.
Sharklet Technologies, Inc.
- 1. ClearSightTM Intraocular Lens Ophthalmology Innovation Summit April 2015 Mark Spiecker 4/27/2015 www.sharklet.com
- 2. • ClearSightTM is the worlds first IOL platform designed to eliminate PCO using the proven SharkletTM technology • Multiple issued patents • Strong in vivo results • Strong addressable market and problem to solve Executive Summary 4/27/2015www.sharklet.com 2
- 4. 80% Reduction in Cell Migration 4/27/2015www.sharklet.com 4 Magin, Chelsea M., May, Rhea M., Drinker, Michael C., Cuevas, Kevin H., Brennan, Anthony B. and Reddy, Shravanthi T., Micropatterned Protective Membranes Inhibit Lens Epithelial Cell Migration in Posterior Capsule Opacification Model. Translational Vision Science & Technology. 4(2), 1-8 (2015).
- 5. 100% Reduction in Treatable PCO 4/27/2015www.sharklet.com 5 Kramer, Gregory D., Werner, Liliana, MacLean, Kyle, Farukhi, Aabid, Gardiner, Gareth L. and Mamalis, Nick., Evaluation of stability and capsular bag opacification with a foldable intraocular lens coupled with a protective membrane in the rabbit model. Journal of Cataract and Refractive Surgery. In Press. (2015).
- 6. Next Generation IOL Platform 4/27/2015www.sharklet.com 6
- 7. ClearSightTM Intraocular Lens Ophthalmology Innovation Summit April 2015 Mark Spiecker 4/27/2015 www.sharklet.com